Not everyone is affected in the same way, though
Skin changes occurred in 19% of women with axillary node-negative, estrogen-receptor positive breast cancer who received adjuvant tamoxifen (n = 1422) compared with 15% of women who received placebo (n = 1437) following primary surgery in a randomized, double-blind study (the NSABP B-14 study)
Similar estimates were obtained in other studies, although according to the LIPIDOGRAM study, which enrolled nearly 34,000 patients, the estimated prevalence may be even higher [278, 280]
So, what is full-time in ABA
It is important to note that this trial had low adherence: only 44% of patients in the trial took at least 75% of their assigned dose (103)
HO-1 Antioxidant and Cytoprotective Pathway BPC-157 activates haem oxygenase-1 (HO-1), a key intracellular antioxidant and cytoprotective enzyme, which modulates oxidative stress, reduces lipid peroxidation, and protects cells from HNE (4-hydroxynonenal)-mediated growth inhibition